Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Buckeye Partners, L.P. stock logo
BPL
Buckeye Partners
$41.46
$41.46
$25.71
$42.65
$6.38B0.71.75 million shsN/A
MQR
Monarques Gold
C$0.23
-8.0%
C$0.23
C$0.15
C$0.42
C$53.60MN/A128,788 shs196,500 shs
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
C$0.06
C$0.07
C$0.04
C$0.09
C$7.64M0.49100,763 shs5,225 shs
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Buckeye Partners, L.P. stock logo
BPL
Buckeye Partners
0.00%0.00%0.00%0.00%0.00%
MQR
Monarques Gold
0.00%0.00%0.00%0.00%0.00%
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
0.00%-15.38%-15.38%-26.67%-31.25%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Buckeye Partners, L.P. stock logo
BPL
Buckeye Partners
N/AN/AN/AN/AN/AN/AN/AN/A
MQR
Monarques Gold
N/AN/AN/AN/AN/AN/AN/AN/A
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Buckeye Partners, L.P. stock logo
BPL
Buckeye Partners
N/AN/AN/AN/A
MQR
Monarques Gold
N/AN/AN/AN/A
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Buckeye Partners, L.P. stock logo
BPL
Buckeye Partners
$4.11B1.55$7.47 per share5.55$28.11 per share1.47
MQR
Monarques Gold
C$30.13M1.78C$0.07 per share3.54C$0.18 per share1.31
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/AN/AC$0.00 per share35.00C$0.01 per shareN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Buckeye Partners, L.P. stock logo
BPL
Buckeye Partners
-$59.03M$1.7923.1615.02N/A-2.43%9.82%4.43%N/A
MQR
Monarques Gold
N/A-C$0.02N/AN/AN/AN/AN/AN/A
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
-C$1.40M-C$0.01N/AN/AN/A-96.50%-35.90%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Buckeye Partners, L.P. stock logo
BPL
Buckeye Partners
$3.007.24%N/A167.60%N/A
MQR
Monarques Gold
N/AN/AN/AN/AN/A
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Buckeye Partners, L.P. stock logo
BPL
Buckeye Partners
0.91
0.91
0.64
MQR
Monarques Gold
19.15
1.52
1.22
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
2.79
0.13
0.84

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Buckeye Partners, L.P. stock logo
BPL
Buckeye Partners
77.51%
MQR
Monarques Gold
N/A
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/A

Insider Ownership

CompanyInsider Ownership
Buckeye Partners, L.P. stock logo
BPL
Buckeye Partners
0.54%
MQR
Monarques Gold
N/A
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
10.21%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Buckeye Partners, L.P. stock logo
BPL
Buckeye Partners
1,600153.92 millionN/AOptionable
MQR
Monarques Gold
N/A233.03 millionN/ANot Optionable
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/A138.81 millionN/ANot Optionable

SRES, BPL, CZL, VM, and MQR Headlines

SourceHeadline
Voyageur Pharmaceuticals executes royalty agreement with Rain Cage CarbonVoyageur Pharmaceuticals executes royalty agreement with Rain Cage Carbon
proactiveinvestors.com - March 13 at 8:07 PM
Voyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug DevelopmentVoyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug Development
thenewswire.com - March 13 at 3:07 PM
Voyageur Pharmaceuticals and API Forge Alliance for Carbon-Based Imaging Drug AdvancementVoyageur Pharmaceuticals and API Forge Alliance for Carbon-Based Imaging Drug Advancement
thenewswire.com - March 4 at 12:38 PM
Voyageur Pharmaceuticals Ltd. Announces Closing of Private PlacementVoyageur Pharmaceuticals Ltd. Announces Closing of Private Placement
thenewswire.com - March 1 at 10:56 AM
Voyageur Pharmaceuticals Ltd. Announces Private PlacementVoyageur Pharmaceuticals Ltd. Announces Private Placement
thenewswire.com - January 16 at 12:54 PM
Voyageur Pharmaceuticals Ltd VMVoyageur Pharmaceuticals Ltd VM
morningstar.com - January 3 at 11:17 PM
Voyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to DirectorsVoyageur Pharmaceuticals Ltd Announces Deferred Share Unit (DSU) Grant to Directors
stockhouse.com - December 21 at 7:10 PM
Voyageur Pharmaceuticals has a really interesting programme for 2024 — Proactive ResearchVoyageur Pharmaceuticals has a really interesting programme for 2024 — Proactive Research
proactiveinvestors.co.uk - December 21 at 2:09 PM
Voyageur Pharmaceuticals Initiates International ExpansionVoyageur Pharmaceuticals Initiates International Expansion
thenewswire.com - December 14 at 5:59 PM
Closing Bell: Voyageur Pharmaceuticals Ltd up on Thursday (VM)Closing Bell: Voyageur Pharmaceuticals Ltd up on Thursday (VM)
theglobeandmail.com - December 8 at 12:35 AM
Closing Bell: Voyageur Pharmaceuticals Ltd up on Monday (VM)Closing Bell: Voyageur Pharmaceuticals Ltd up on Monday (VM)
theglobeandmail.com - October 24 at 12:33 AM
Voyageur Pharmaceuticals Achieves Milestone in the Development of HDXBa Barium Contrast MediaVoyageur Pharmaceuticals Achieves Milestone in the Development of HDXBa Barium Contrast Media
stockhouse.com - September 14 at 1:17 PM
Voyageur Pharmaceuticals achieves milestone developing HDXBa barium contrast mediaVoyageur Pharmaceuticals achieves milestone developing HDXBa barium contrast media
proactiveinvestors.com - September 14 at 1:17 PM
Closing Bell: Voyageur Pharmaceuticals Ltd up on Wednesday (VM)Closing Bell: Voyageur Pharmaceuticals Ltd up on Wednesday (VM)
theglobeandmail.com - September 7 at 8:29 AM
Closing Bell: Voyageur Pharmaceuticals Ltd down on Tuesday (VM)Closing Bell: Voyageur Pharmaceuticals Ltd down on Tuesday (VM)
theglobeandmail.com - June 20 at 9:07 PM
Voyageur Pharmaceuticals completes field work at Frances Creek project in British ColumbiaVoyageur Pharmaceuticals completes field work at Frances Creek project in British Columbia
proactiveinvestors.com - May 31 at 3:13 PM
Voyageur Pharmaceuticals Partners with Rain Cage Carbon to Revolutionize Medical Imaging with Nanocarbon-Based Contrast DrugsVoyageur Pharmaceuticals Partners with Rain Cage Carbon to Revolutionize Medical Imaging with Nanocarbon-Based Contrast Drugs
finance.yahoo.com - May 24 at 10:27 AM
Voyageur Pharmaceuticals unveils pioneering agreement with Rain Cage CarbonVoyageur Pharmaceuticals unveils pioneering agreement with Rain Cage Carbon
proactiveinvestors.com - May 24 at 10:27 AM
Closing Bell: Voyageur Pharmaceuticals Ltd flat on Tuesday (VM)Closing Bell: Voyageur Pharmaceuticals Ltd flat on Tuesday (VM)
theglobeandmail.com - May 10 at 2:29 PM
Closing Bell: Voyageur Pharmaceuticals Ltd flat on Wednesday (VM)Closing Bell: Voyageur Pharmaceuticals Ltd flat on Wednesday (VM)
theglobeandmail.com - May 4 at 12:58 AM
Closing Bell: Voyageur Pharmaceuticals Ltd down on Monday (VM)Closing Bell: Voyageur Pharmaceuticals Ltd down on Monday (VM)
theglobeandmail.com - May 2 at 12:14 AM
Closing Bell: Voyageur Pharmaceuticals Ltd up on Friday (VM)Closing Bell: Voyageur Pharmaceuticals Ltd up on Friday (VM)
theglobeandmail.com - April 29 at 4:26 PM
Closing Bell: Voyageur Pharmaceuticals Ltd flat on Thursday (VM)Closing Bell: Voyageur Pharmaceuticals Ltd flat on Thursday (VM)
theglobeandmail.com - April 28 at 6:06 PM
Closing Bell: Voyageur Pharmaceuticals Ltd flat on Monday (VM)Closing Bell: Voyageur Pharmaceuticals Ltd flat on Monday (VM)
theglobeandmail.com - April 26 at 2:36 AM

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Buckeye Partners logo

Buckeye Partners

NYSE:BPL
Buckeye Partners, L.P. owns and operates liquid petroleum products pipelines in the United States and internationally. The company operates through three segments: Domestic Pipelines & Terminals, Global Marine Terminals, and Merchant Services. The Domestic Pipelines & Terminals segment transports liquid petroleum products, including gasoline, jet fuel, and various distillates. This segment also provides crude oil services, including train loading/unloading, storage, and throughput; and turn-key operations and maintenance, asset development, and construction services for third-party pipeline, terminal, and energy assets, as well as operates and/or maintains third-party pipelines. It owns and operates approximately 6,000 miles of pipeline located primarily in the northeastern and upper midwestern portions of the United States, and services 100 delivery locations; 110 active terminals that provide bulk storage and throughput services with aggregate storage capacity of 55 million barrels; and 2 underground propane storage caverns. The Global Marine Terminals segment provides marine accessible bulk storage and blending, rail and truck rack loading/unloading, and petroleum processing services located primarily in the East Coast and Gulf Coast regions of the United States, as well as in the Caribbean. This segment owns and operates seven liquid petroleum products and crude oil terminals. The Merchant Services segment is involved in the wholesale distribution of refined petroleum products, including gasoline, natural gas liquids, propane, ethanol, and biodiesel, as well as petroleum distillates, such as heating oil, diesel fuel, kerosene, and fuel oil. This segment also provides fuel oil supply, butane, and distribution services. Buckeye GP LLC serves as the general partner of the company. Buckeye Partners, L.P. was founded in 1886 and is based in Houston, Texas.

Monarques Gold

CVE:MQR
Monarques Gold Corporation engages in the acquisition, exploration, and development of mining properties in Canada. The company has approximately 240 square kilometers of gold properties, including the Beaufor Mine; the Croinor Gold and Wasamac advanced projects; and the Camflo and Beacon mills, as well as 6 promising exploration projects located in the Val-d'Or area, Quebec. It also offers toll milling services through its 1,200 tpd Camflo mill. The company was formerly known as Monarques Resources Inc. and changed its name to Monarques Gold Corporation in January 2015. Monarques Gold Corporation was incorporated in 2011 and is headquartered in Saint-Sauveur, Canada.
Voyageur Pharmaceuticals logo

Voyageur Pharmaceuticals

CVE:VM
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.